MDxHealth SA Operating Margin 2018-2025 | MDXH
Current and historical operating margin for MDxHealth SA (MDXH) over the last 10 years. The current operating profit margin for MDxHealth SA as of March 31, 2025 is -37.74%.
| MDxHealth SA Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.09B | $-0.02B | -24.47% |
| 2024-12-31 | $0.09B | $-0.03B | -27.78% |
| 2024-09-30 | $0.08B | $-0.03B | -30.95% |
| 2024-06-30 | $0.08B | $-0.03B | -31.25% |
| 2024-03-31 | $0.08B | $-0.03B | -34.67% |
| 2023-12-31 | $0.07B | $-0.03B | -40.00% |
| 2023-06-30 | $0.04B | $-0.03B | -67.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.104B | $0.090B |
| MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.182B | 58.76 |
| Doximity (DOCS) | United States | $11.140B | 51.57 |
| Hims & Hers Health (HIMS) | United States | $10.623B | 110.37 |
| Tempus AI (TEM) | United States | $10.245B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.558B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.855B | 60.24 |
| Hinge Health (HNGE) | United States | $3.480B | 0.00 |
| Privia Health (PRVA) | United States | $2.672B | 182.67 |
| Enovis (ENOV) | United States | $1.911B | 10.66 |
| Phreesia (PHR) | United States | $1.730B | 0.00 |
| 10x Genomics (TXG) | United States | $1.602B | 0.00 |
| Schrodinger (SDGR) | United States | $1.538B | 0.00 |
| Azenta (AZTA) | United States | $1.504B | 69.89 |
| Omnicell (OMCL) | United States | $1.396B | 24.63 |
| Evolent Health (EVH) | United States | $1.377B | 117.30 |
| Clover Health Investments (CLOV) | United States | $1.318B | 0.00 |
| Claritev (CTEV) | United States | $0.699B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.612B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.520B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.440B | 131.50 |
| Outset Medical (OM) | United States | $0.365B | 0.00 |
| TruBridge (TBRG) | United States | $0.340B | 755.33 |
| Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.168B | 0.00 |
| American Well (AMWL) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.131B | 0.00 |
| Pulmonx (LUNG) | United States | $0.110B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.049B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |